Beta Bionics (BBNX) Shares Outstanding (2023 - 2026)

Beta Bionics has disclosed Shares Outstanding (Entity) across 4 years of filings, most recently posting $45.0 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 3.49% year-over-year to $45.0 million; the TTM figure through Jun 2026 stood at $45.0 million (up 3.49% YoY), while the FY2025 annual figure was $44.4 million, up 565.3% from the prior year.
• Shares Outstanding (Entity) came in at $45.0 million for Q2 2026 at Beta Bionics, up from $44.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $45.0 million in Q2 2026 to a low of $6.0 million in Q4 2023.
• Average Shares Outstanding (Entity) over 4 years is $25.8 million, with a median of $30.7 million recorded in 2025.
• Year-over-year, Shares Outstanding (Entity) surged 565.3% in 2025 and grew 3.49% in 2026.
• Over 4 years, Shares Outstanding (Entity) stood at $6.0 million in 2023, then rose by 10.74% to $6.7 million in 2024, then surged by 565.3% to $44.4 million in 2025, then rose by 1.4% to $45.0 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $45.0 million in Q2 2026, $44.6 million in Q1 2026, and $44.4 million in Q4 2025.